Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 5/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13018678 | 0.94 | KIF11 (0.45) | KIF11KDM4ELMNAF2CA1 | |
| SCHEMBL3663983 | 0.89 | PTGER4 (0.46) | PTGER4KIF11KDM4ELMNAF2 | |
| SCHEMBL13063217 | 0.85 | KIF11 (0.44) | KIF11KDM4ELMNAF2CA1 | |
| SCHEMBL13768194 | 0.85 | KIF11 (0.44) | KIF11KDM4ELMNAF2CA1 | |
| SCHEMBL13767956 | 0.80 | KIF11 (0.35) | KIF11SCARB1LMNAF2CA1 | |
| SCHEMBL22852987 | 0.76 | KDM4E (0.39) | KIF11KDM4ELMNAPOLBPPARG | |
| SCHEMBL19757516 | 0.74 | CNR2 (0.37) | PTGER4SCARB1LMNAPPARG | |
| SCHEMBL20252383 | 0.74 | POLB (0.41) | PTGER4KDM4ELMNAF2PLAU | |
| SCHEMBL24604375 | 0.73 | KIF11 (0.44) | KIF11KDM4ELMNAMAPK8PPARG | |
| SCHEMBL986790 | 0.73 | TSHR (0.48) | KIF11KDM4ELMNAF2PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546505-B2 | Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-10-01 | — | — | US | disclosed |
| US-20100331509-A1 | Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-12-30 | — | — | US | disclosed |
| EP-2234969-A2 | CARBAZOLE-BASED HOLE TRANSPORT AND /OR ELECTRON BLOCKING MATERIALS AND /OR HOST POLYMER MATERIALS | Georgia Tech Research Corporation (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009080799-A2 | CARBAZOLE-BASED HOLE TRANSPORT AND /OR ELECTRON BLOCKING MATERIALS AND /OR HOST POLYMER MATERIALS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331509-A1 | Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials | OCIAD1, HPD, OXA1L | PTGER4 1209/4885KIF11 3251/4885SCARB1 1553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.